{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T18:03:37Z","timestamp":1784570617842,"version":"3.55.0"},"reference-count":29,"publisher":"Public Library of Science (PLoS)","issue":"7","license":[{"start":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T00:00:00Z","timestamp":1784505600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100001458","name":"American Kennel Club Canine Health Foundation","doi-asserted-by":"publisher","award":["AKC 2446"],"award-info":[{"award-number":["AKC 2446"]}],"id":[{"id":"10.13039\/100001458","id-type":"DOI","asserted-by":"publisher"}]},{"name":"AFBS","award":["AFBS donation 2022"],"award-info":[{"award-number":["AFBS donation 2022"]}]},{"name":"CRB-Anim infrastructure","award":["ANR-11-INBS-0003"],"award-info":[{"award-number":["ANR-11-INBS-0003"]}]},{"name":"CNRS"},{"DOI":"10.13039\/100015510","name":"IBISA","doi-asserted-by":"crossref","award":["specific BRC call (2022-2024)"],"award-info":[{"award-number":["specific BRC call (2022-2024)"]}],"id":[{"id":"10.13039\/100015510","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS One"],"abstract":"\n Background<\/jats:title>\n \n Histiocytic sarcoma (HS) is a rare but highly aggressive neoplasm in humans, with limited knowledge on indicators markers and no standardized treatment. Dogs naturally develop HS, offering a powerful comparative model. Activating mutations in\n PTPN11<\/jats:italic>\n , affecting two recurrent hotspots (E76 and G503), are the most frequent drivers of canine HS and are strongly associated with the disseminated form (DHS). While DHS is typically considered metastatic, we hypothesize that multiple independent tumor clones may arise within the same individual.\n <\/jats:p>\n <\/jats:sec>\n \n Methods<\/jats:title>\n \n We investigated clonal heterogeneity in 38 dogs affected with DHS presenting tumors in both abdominal and thoracic organs.\n PTPN11<\/jats:italic>\n hotspot mutations were analyzed by high-sensitivity droplet digital PCR (ddPCR) to detect low-abundance variants. The frequency of divergent mutations between tumor sites was used to infer the proportion of cases arising from independent clonal origins.\n <\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n \n Divergent\n PTPN11<\/jats:italic>\n mutations were directly observed in 3 of 28 dogs with\n PTPN11<\/jats:italic>\n -mutated tumor pairs. After correcting for the limited detectability inherent to hotspot-based analysis, we estimated that, in this cohort, up to 24\u201345% of DHS cases may harbor clonally independent\n PTPN11<\/jats:italic>\n mutations in distinct tumors. In addition, analysis of somatic mutations and copy number variants by Next Generation Sequencing (NGS) in two cell lines derived from the same patient confirmed the independent origin of the clones.\n <\/jats:p>\n <\/jats:sec>\n \n Conclusions<\/jats:title>\n Our findings suggest that a significant numbers of dogs with DHS develop several genetically distinct HS lesions either simultaneously or within a short time interval. This need to be confirmed in larger cohorts but this clonal diversity challenges the assumption that DHS is predominantly metastatic and has major implications for prognosis, therapeutic strategies, and the use of canine HS as a comparative model for human disease. Further exploration of clonal evolution in HS is warranted to improve treatment approaches in both species.<\/jats:p>\n <\/jats:sec>","DOI":"10.1371\/journal.pone.0345429","type":"journal-article","created":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T17:26:41Z","timestamp":1784568401000},"page":"e0345429","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":0,"title":["Identification of divergent PTPN11 mutations in canine histiocytic sarcomas reveals evidence of an independent clonal origin"],"prefix":"10.1371","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5094-0792","authenticated-orcid":true,"given":"St\u00e9phanie","family":"Mottier","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Armel","family":"Houel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Solveig","family":"Bouchard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charline","family":"Bianchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louis","family":"Le Nezet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Guyon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"St\u00e9phane","family":"Dreano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Derrien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jer\u00f4me","family":"Abadie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Andr\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2418-1868","authenticated-orcid":true,"given":"Beno\u00eet","family":"H\u00e9dan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2026,7,20]]},"reference":[{"issue":"22","key":"pone.0345429.ref001","doi-asserted-by":"crossref","first-page":"2672","DOI":"10.1182\/blood-2016-01-690636","article-title":"Revised classification of histiocytoses and neoplasms of the macrophage-dendritic cell lineages","volume":"127","author":"J-F Emile","year":"2016","journal-title":"Blood"},{"issue":"4","key":"pone.0345429.ref002","doi-asserted-by":"crossref","first-page":"951","DOI":"10.3324\/haematol.2019.230375","article-title":"Genomic profiling of primary histiocytic sarcoma reveals two molecular subgroups","volume":"105","author":"C Egan","year":"2020","journal-title":"Haematologica"},{"issue":"10","key":"pone.0345429.ref003","doi-asserted-by":"crossref","first-page":"2530","DOI":"10.1182\/bloodadvances.2024015208","article-title":"Characterization and treatment outcomes of malignant histiocytoses in a retrospective series of 141 cases in France","volume":"9","author":"C Bigenwald","year":"2025","journal-title":"Blood Adv"},{"issue":"6","key":"pone.0345429.ref004","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1002\/ijc.32991","article-title":"PTPN11 mutations in canine and human disseminated histiocytic sarcoma","volume":"147","author":"B H\u00e9dan","year":"2020","journal-title":"Int J Cancer"},{"issue":"7","key":"pone.0345429.ref005","doi-asserted-by":"crossref","first-page":"505","DOI":"10.3390\/genes10070505","article-title":"Activating Mutations in PTPN11 and KRAS in Canine Histiocytic Sarcomas","volume":"10","author":"M Takada","year":"2019","journal-title":"Genes (Basel)"},{"issue":"2","key":"pone.0345429.ref006","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1111\/vco.12357","article-title":"Gain-of-function mutation in PTPN11 in histiocytic sarcomas of Bernese Mountain Dogs","volume":"16","author":"T Thaiwong","year":"2018","journal-title":"Vet Comp Oncol"},{"issue":"1","key":"pone.0345429.ref007","doi-asserted-by":"crossref","first-page":"8512","DOI":"10.1038\/s41598-023-35813-1","article-title":"Whole exome and transcriptome analysis revealed the activation of ERK and Akt signaling pathway in canine histiocytic sarcoma","volume":"13","author":"H Asada","year":"2023","journal-title":"Sci Rep"},{"issue":"8","key":"pone.0345429.ref008","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.3390\/genes15081050","article-title":"Canine Histiocytic and Hemophagocytic Histiocytic Sarcomas Display KRAS and Extensive PTPN11\/SHP2 Mutations and Respond In Vitro to MEK Inhibition by Cobimetinib","volume":"15","author":"Y-T Yang","year":"2024","journal-title":"Genes (Basel)"},{"issue":"2","key":"pone.0345429.ref009","article-title":"Canine Histiocytic Malignancies-Challenges and Opportunities","volume":"3","author":"K Kennedy","year":"2016","journal-title":"Vet Sci"},{"issue":"9","key":"pone.0345429.ref010","article-title":"Comparison of the clinical characteristics of histiocytic sarcoma in Bernese mountain dogs and flat-coated retrievers","volume":"9","author":"SA Erich","year":"2022","journal-title":"Vet Sci"},{"key":"pone.0345429.ref011","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1186\/1471-2407-11-201","article-title":"Molecular cytogenetic characterization of canine histiocytic sarcoma: A spontaneous model for human histiocytic cancer identifies deletion of tumor suppressor genes and highlights influence of genetic background on tumor behavior","volume":"11","author":"B Hedan","year":"2011","journal-title":"BMC Cancer"},{"key":"pone.0345429.ref012","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1186\/1471-2407-11-201","article-title":"Molecular cytogenetic characterization of canine histiocytic sarcoma: A spontaneous model for human histiocytic cancer identifies deletion of tumor suppressor genes and highlights influence of genetic background on tumor behavior","volume":"11","author":"B Hedan","year":"2011","journal-title":"BMC Cancer"},{"issue":"4","key":"pone.0345429.ref013","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.jcpa.2014.07.003","article-title":"Immunohistochemical expression of ionized calcium binding adapter molecule 1 in cutaneous histiocytic proliferative, neoplastic and inflammatory disorders of dogs and cats","volume":"151","author":"F Pierezan","year":"2014","journal-title":"J Comp Pathol"},{"issue":"2","key":"pone.0345429.ref014","doi-asserted-by":"crossref","first-page":"276","DOI":"10.3390\/cancers14020276","article-title":"Canine Oral Melanoma Genomic and Transcriptomic Study Defines Two Molecular Subgroups with Different Therapeutical Targets","volume":"14","author":"A Prouteau","year":"2022","journal-title":"Cancers (Basel)"},{"issue":"1","key":"pone.0345429.ref015","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1038\/s41598-020-80332-y","article-title":"Circulating tumor DNA is detectable in canine histiocytic sarcoma, oral malignant melanoma, and multicentric lymphoma","volume":"11","author":"A Prouteau","year":"2021","journal-title":"Sci Rep"},{"issue":"14","key":"pone.0345429.ref016","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1093\/bioinformatics\/btp324","article-title":"Fast and accurate short read alignment with Burrows-Wheeler transform","volume":"25","author":"H Li","year":"2009","journal-title":"Bioinformatics"},{"issue":"4","key":"pone.0345429.ref017","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1009395","article-title":"Identification of common predisposing loci to hematopoietic cancers in four dog breeds","volume":"17","author":"B H\u00e9dan","year":"2021","journal-title":"PLoS Genet"},{"key":"pone.0345429.ref018","author":"E Venkatraman","year":"2017"},{"key":"pone.0345429.ref019","article-title":"Epidemiology, pathology, and genetics of histiocytic sarcoma in the Bernese mountain dog breed","author":"J Abadie","year":"2009","journal-title":"J Hered"},{"issue":"1","key":"pone.0345429.ref020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/030098588602300101","article-title":"Malignant histiocytosis of Bernese mountain dogs","volume":"23","author":"PF Moore","year":"1986","journal-title":"Vet Pathol"},{"issue":"4","key":"pone.0345429.ref021","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1111\/vco.12252","article-title":"Clinical prognostic factors in canine histiocytic sarcoma","volume":"15","author":"NG Dervisis","year":"2017","journal-title":"Vet Comp Oncol"},{"key":"pone.0345429.ref022","doi-asserted-by":"crossref","first-page":"106264","DOI":"10.1016\/j.tvjl.2024.106264","article-title":"Antitumor effects of inhibitors of ERK and Akt pathways in canine histiocytic sarcoma cell lines","volume":"308","author":"H Sakuma","year":"2024","journal-title":"Vet J"},{"issue":"4","key":"pone.0345429.ref023","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1111\/vco.12518","article-title":"Prognostic and predictive significance of KIT protein expression and c-kit gene mutation in canine cutaneous mast cell tumours: A consensus of the Oncology-Pathology Working Group","volume":"17","author":"DH Thamm","year":"2019","journal-title":"Vet Comp Oncol"},{"issue":"7","key":"pone.0345429.ref024","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1111\/jsap.12069","article-title":"Heterogeneity of internal tandem duplications in the c-kit of dogs with multiple mast cell tumours","volume":"54","author":"Y Amagai","year":"2013","journal-title":"J Small Anim Pract"},{"issue":"1","key":"pone.0345429.ref025","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s13620-025-00311-5","article-title":"Comparative genomic analysis of multiple mammary tumors from a single dog: whole-genome sequencing study","volume":"78","author":"K Kim","year":"2025","journal-title":"Ir Vet J"},{"issue":"21","key":"pone.0345429.ref026","doi-asserted-by":"crossref","first-page":"30241","DOI":"10.18632\/oncotarget.7148","article-title":"Intratumoral KIT mutational heterogeneity and recurrent KIT\/ PDGFRA mutations in KIT\/PDGFRA wild-type gastrointestinal stromal tumors","volume":"7","author":"J Gao","year":"2016","journal-title":"Oncotarget"},{"issue":"8041","key":"pone.0345429.ref027","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1038\/s41586-024-08133-1","article-title":"Polyclonal-to-monoclonal transition in colorectal precancerous evolution","volume":"636","author":"Z Lu","year":"2024","journal-title":"Nature"},{"issue":"1","key":"pone.0345429.ref028","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1186\/s13073-022-01083-1","article-title":"Whole genome sequencing reveals the independent clonal origin of multifocal ileal neuroendocrine tumors","volume":"14","author":"N M\u00e4kinen","year":"2022","journal-title":"Genome Med"},{"key":"pone.0345429.ref029","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.mrrev.2018.05.001","article-title":"Multiclonal tumor origin: Evidence and implications","volume":"777","author":"BL Parsons","year":"2018","journal-title":"Mutat Res Rev Mutat Res"}],"container-title":["PLOS One"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0345429","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T17:26:49Z","timestamp":1784568409000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0345429"}},"subtitle":[],"editor":[{"given":"Douglas H.","family":"Thamm","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2026,7,20]]},"references-count":29,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2026,7,20]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0345429","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,20]]}}}